NAD+ is a central redox coenzyme studied for mitochondrial signaling, aging biology, and cellular repair pathways.
Pre-loaded with a typical NAD+ vial. Change any value to match what you actually have.
What published research and laboratory protocols actually document for NAD+. Where a compound has no single microgram figure, we say so rather than inventing one.
| Reported amount | Frequency | Route | Where this figure comes from |
|---|---|---|---|
| 300 mg – 1000 mg | daily in study protocols | oral | Human oral nicotinamide riboside studies commonly cited in NAD+ precursor literature These values describe NAD+ precursors, not direct research-grade NAD+ powder. |
| 900 mg | single study dose | oral | Acute human cerebral NAD+ measurement study using nicotinamide riboside Reference information only; the studied material was nicotinamide riboside. |
People searching this page also look for: nad+ peptide dosage, nad+ peptide dosage per day, nad+ peptide injection dosage per day, nad+ peptide injection dosage, nad+ peptide dosage chart, nad+ peptide dosage per week, nad plus peptide dosage, dosage for nad+ peptide.
NAD+ is not a peptide; it is a nucleotide-derived coenzyme used in virtually every cell. Research interest centers on its role in redox reactions, mitochondrial metabolism, sirtuin signaling, PARP activity, and age-associated changes in cellular energy handling. Education pages often group NAD+ with peptide protocols because it is sold in similar lyophilized formats, but mechanistically it belongs to metabolism and coenzyme biology.
Published human work most often studies NAD+ precursors such as nicotinamide riboside or nicotinamide mononucleotide, while direct NAD+ material appears in more limited pharmacokinetic and infusion-oriented discussions. Any research-grade NAD+ powder is Research Use Only and is not the same thing as a regulated drug product. Reported ranges below are reference points from published precursor or NAD-related literature, not instructions for use.
NAD+ cycles between oxidized and reduced forms to shuttle electrons through glycolysis, the TCA cycle, and oxidative phosphorylation. It also serves as a substrate for enzymes including sirtuins, PARPs, CD38, and other NAD-consuming systems. When NAD+ availability changes, downstream effects can include altered mitochondrial respiration, DNA damage signaling, inflammatory tone, and cellular stress responses. Researchers study both direct NAD+ and precursor strategies because cells tightly regulate NAD synthesis, salvage, and consumption.
mitochondrial function · aging biology · redox metabolism · cellular stress response · NAD precursor pharmacology
NAD+ is studied by mitochondrial biologists, aging researchers, nutrition scientists, and pharmacologists. Clinical investigators more commonly study oral NAD+ precursors, while analytical labs examine NAD+ handling, stability, and compartment-specific measurement.
Research-grade lyophilized NAD+ is commonly stored frozen and protected from moisture and light; reconstituted material is typically kept refrigerated and used promptly in laboratory settings.
NAD+ is often discussed beside mitochondrial and recovery-focused compounds, but the strongest literature is on NAD metabolism rather than peptide stacking. Researchers usually separate NAD+ or precursor variables from other interventions so changes in redox markers, methylation demand, and mitochondrial readouts can be interpreted cleanly.
The questions people actually search for, answered plainly.
For education only: published human studies most often report oral NAD+ precursor amounts, commonly in the hundreds of milligrams to 1 gram daily. That is not a recommendation and is not the same as dosing research-grade NAD+.
Research suppliers commonly discuss 5-20 mL reconstitution volumes for larger NAD+ vials, depending on target concentration. Reconstitution math is a lab calculation, not a human-use instruction.
Daily values in the literature usually refer to oral precursors such as nicotinamide riboside. Direct NAD+ protocols vary by research model and should be read from the original paper.
A useful chart should separate precursor studies, direct NAD+ analytical work, route, concentration, and species. Combining them into one dosing chart can be misleading.
Some precursor studies measure NAD-related metabolites within hours, while tissue or functional endpoints are usually assessed over weeks. Timing depends on the assay and model.
There is no single practical half-life for all NAD+ research because NAD+ is rapidly turned over and compartmentalized. Researchers often track metabolite pools rather than plasma half-life alone.
It can be studied alongside other compounds, but clean protocols isolate variables. Research-use-only material should not be treated as a wellness stack or drug substitute.
Primary literature on NAD+. Open access where available.
Every citation above was programmatically checked against the NCBI PubMed database. Titles shown are the official indexed titles, not paraphrases.
Our support assistant walks through reconstitution, syringe units, storage, and how to read a Certificate of Analysis. Free, no account.
Read the guides